Allam J-P, Novak N
Klinik und Poliklinik für Dermatologie und Allergologie, Universitätsklinikum Bonn, Sigmund-Freud-Str. 25, 53105, Bonn, Deutschland.
Hautarzt. 2017 Apr;68(4):265-270. doi: 10.1007/s00105-017-3961-0.
Allergen-specific immunotherapy is accompanied by multiple changes on the cellular and humoral level. A shift of Th2 immune responses towards immune responses of the Th1 type, which goes along with an increase of regulatory T cells and B cells, IL-10 as well as reduction of effector cells and eosinophils in the tissue, combined with lower IgE production in favor of higher IgG4 production, are regarded as key mechanisms of allergen-specific immunotherapy . A better understanding of immunologic pathways of specific immunotherapy would be essential for the improvement of this therapy as well as for the development of reliable biomarkers capable to monitor therapeutic responses as well as compliance of the patients.
变应原特异性免疫疗法伴随着细胞和体液水平的多种变化。Th2免疫反应向Th1型免疫反应转变,同时调节性T细胞和B细胞、IL-10增加,组织中效应细胞和嗜酸性粒细胞减少,IgE产生降低而有利于更高的IgG4产生,这些被视为变应原特异性免疫疗法的关键机制。更好地理解特异性免疫疗法的免疫途径对于改进该疗法以及开发能够监测治疗反应和患者依从性的可靠生物标志物至关重要。